Following the AGM, the Company’s Board of Directors has approved the implementation of a reverse share split of its ordinary shares at a ratio of 1-for-50 (the “Reverse Split”).

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Adamas Trust, Inc. (Nasdaq: ADAM) (“Adamas,” the “Company,” “we,” “our” or “us”) today reported results for the three months and year ended December 31, ...

Davis Real Estate Fund underperformed its benchmark in 2025 as passive inflows dominated the market, increasing the gravitational attraction of size and making the big bigger, all at the expense of ...

Since the start of the new year, interest has been growing in who will succeed North Korean leader Kim Jongun as his heir.

Q2 2026 Earnings Call February 16, 2026 6:01 PM ESTCompany ParticipantsStephen Mikkelsen - Group CEO, Director & MDWarrick R.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026 Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-2.39 EPS, expectations were ...

The latest evolution continues a lineage with a striking design language inspired by Kiriko, the traditional Japanese cut‑glass technique known for its brilliance and geometric precision. The result ...

US Foods Holding Corp. (NYSE: USFD), one of the largest foodservice distributors in the United States, today announced ...

Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) ("Realbotix" or the "Parent Company"), a leader in AI-powered humanoid robots, announces it has entered into a definitive agreement with ...

Saga Communications, Inc. (Nasdaq - SGA) (the 'Company”, 'Saga” or 'our”) today announced that its Board of Directors ('Board”) declared a quarterly cash dividend of $0.25 per share. The dividend will ...

CNW/ - Chorus Aviation Inc. (TSX: CHR) ("Chorus") announced today that it has received approval from the Toronto Stock Exchange (the "TSX") respecting ...

MIT researchers have built an AI language model that learns the internal coding patterns of a yeast species widely used to manufacture protein-based drugs, then rewrites gene sequences to push protein ...